AzTrials
AzTrials

Very Low Birth Weight InfantNCT05483231

The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants

A study testing Family integrated care intervention group and Routine nursing care group in people with Very Low Birth Weight Infant, run by Children's Hospital of Fudan University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study will explore the effect of Family integrated care (FICare) on the level of melatonin and other clinical outcomes in very low birth weight infants (VLBWIs) by integrating families into the neonatal intensive care unit (NICU) care team and participating in the daily care of VLBWIs, as well as the influence of… Read more about this study

Who is it for?
Ages 0 to 24 hours
Conditions the study is for
Very Low Birth Weight Infant
What is being tested?
Family integrated care intervention group and Routine nursing care group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteChina
Study dates
1 Dec 2023to 30 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 24 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Birth weight < 1500g;
  • Gestational age < 32w;
  • Admit within 24 hours of birth;
  • The parents are conscious and able to cooperate, have certain learning and reading comprehension skills, and are capable of caring for their babies. They are committed to receiving training and caring for their babies for not less than 6 hours a day for at least 21 days;
  • Voluntarily participate in this study and sign informed consent.

Who cannot join

  • Newborns who require palliative care or surgical intervention;
  • OI (oxygenation index) <300 ;
  • Newborns with severe congenital malformations;

Trial locations and contacts

1 site in 1 country.

Xiaojing Hu, PhD contact

+8618017590869

humama2015@126.com

China1 site
  • Children's Hospital of Fudan University

    Shanghai, Shanghai Municipality, 201102

    Xiaojing Hu, PhD, +8618017590869, humama2015@126.com

    Yi Zhang, Master, +8618071608186, 20211170025@fudan.edu.cn

Other trials in China

About this study

Official title: The Effect of Family Integrated Care on Melatonin Level in Very Low Birth Weight Infants in Neonatal Intensive Care Unit: A Multicenter Randomized Controlled Trial

This study will explore the effect of Family integrated care (FICare) on the level of melatonin and other clinical outcomes in very low birth weight infants (VLBWIs) by integrating families into the neonatal intensive care unit (NICU) care team and participating in the daily care of VLBWIs, as well as the influence of FIcare on parents' outcomes.

Read the detailed description

This study is a multicenter randomized controlled trial which mainly explores the effect of Family integrated care (FICare) on melatonin levels in very low birth weight infants (VLBWIs) in neonatal intensive care unit (NICU). The intervention group will use a FICare intervention program, mainly for families who have been fully trained by the NICU professional team and need to stay in the NICU to accompany and care for the VLBWIs for not less than 6 hours a day for at least 3 weeks. All non-medical care measures and developmental supportive care will be provided by parents as much as possible. The control group received routine nursing interventions in which all non-medical interventions are led by NICU staff and without parental involvement. The level of melatonin, clinical and parental outcomes in VLBWIs are compared between the intervention group and the control group to evaluate the effect of FICare intervention program.

Being tested
Family integrated care intervention group, Routine nursing care group
Keywords
Family integrated care, Melatonin

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family integrated care intervention groupBehavioural

    If the very low birth weight infants' vital signs are stable at 32 weeks of corrected gestational age, parents who have been fully trained will provide all non-medical care measures and developmental care for the VLBWIs in the NICU for not less than 6 hours per day for at least 3 weeks, and other medical practice and care measures will be the same as the routine group.

  • Routine nursing care groupBehavioural

    Routine practice and in-hospital education will be given to the very low birth weight infants and parents. All care measures will be led by the nursing staff, without the participation of parents.

Study groups in NCT05483231
Study groupRoleWhat they receive
Family integrated care intervention groupExperimentalProvide Family integrated care for very low birth weight infants in the NICU.
Receives: Behavioral: Family integrated care intervention group
Routine nursing care groupOtherPerform routine nursing care for very low birth weight infants in the NICU.
Receives: Behavioral: Routine nursing care group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes on the level of Melatonin in very low birth weight infants

    At 32 weeks of corrected gestational age (baseline) and day 21 after the implementation of FICare intervention, melatonin will be quantitatively measured by high performance liquid chromatography-mass spectrometry (HPLC-MS) with saliva samples collected by a specially-assigned person.

    Measured: From baseline to day 21 after the implementation of Family integrated care intervention

Secondary outcomes (6)
  1. Breast feeding rate

    Data will be acquired at the day 21 after the implementation of FICare intervention by a specially-assigned person. Breastfeeding rate = number of VLBWI fed from mother's milk/total number of VLBWI enrolled in each group *100%.

    Measured: At the day 21 after the implementation of Family integrated care intervention

  2. Changes in maternal milk volume

    At 32 weeks of corrected gestational age (baseline) and day 21 after the implementation of FICare intervention, maternal milk volume will be collected from lactation diary records issued before the intervention.

    Measured: From baseline to day 21 after the implementation of Family integrated care intervention

  3. Rate of weight gain

    Weight is measured by a parent or nurse. Rate of weight gain = ( Weight measured at day 21 after the intervention - weight measured at 32 weeks of corrected gestational age)/total number of intervention days.

    Measured: From baseline to day 21 after the implementation of Family integrated care intervention

  4. Incidence of complications related to preterm birth

    Complications related to preterm birth include neonatal sepsis, bronchopulmonary dysplasia (BPD), intraventicular hemorrhage (IVH), periventricular leukinomalacia (PVL), and retinopathy of prematurity (ROP). These complications are diagnosed by a neonatologist. If any of these conditions occurred during the intervention, complications related to preterm birth would be considered. Data will be obtained from the case system or data collection form.

    Measured: Through study completion, about an average of 21 days

  5. Length of hospitalization

    Length of hospitalization refers to the total number of days from 32 weeks of corrected gestational age (baseline) to the day of discharge. Data will be obtained from the case system.

    Measured: Through study completion, about an average of 21 days

  6. Growth rate of head circumference

    Head circumference is measured by a parent or nurse. Growth rate of head circumference = ( head circumference measured at day 21 after the intervention - head circumference measured at 32 weeks of corrected gestational age)/total number of intervention days.

    Measured: From baseline to day 21 after the implementation of Family integrated care intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2022
  2. Study start1 Dec 2023 (estimated)
  3. Primary completion30 Apr 2024 (estimated)
  4. Study completion30 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
64 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05483231
Sponsor's protocol ID
2021-453
Status last verified
Aug 2023
First submitted
28 Jun 2022
Last updated
14 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Family integrated care intervention group and Routine nursing care group in people with Very Low Birth Weight Infant, run by Children's Hospital of Fudan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yi Zhang, Master (+8618071608186, 20211170025@fudan.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes on the level of Melatonin in very low birth weight infants (time frame: From baseline to day 21 after the implementation of Family integrated care intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in